Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Classement en actions #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Prix de l'action
$4.84
Capitalisation boursière
$633.18M
Changement (1 jour)
3.20%
Changement (1 an)
0.00%
Pays
GB
Échange Exscientia plc (EXAI)

Catégorie

Healthcare
Ratio P/S pour Exscientia plc (EXAI)
Ratio P/S au April 2026 TTM : 23.78
Selon les derniers rapports financiers et le cours de l'action de Exscientia plc, le ratio cours/ventes actuel (TTM) est 23.78. À la fin de 2022, le ratio P/S était de 24.27.
Historique du ratio P/S pour Exscientia plc de 2019 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 23.78 -23.72%
2023 31.18 28.46%
2022 24.27 -72.05%
2021 86.85 -52.06%
2020 181.16 -12.07%
2019 206.03 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.32 -86.04%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.42 -60.38%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.60 -76.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.36 -73.27%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -87.22%
AU